Osteoporosis

Li L et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4185-0

Kanis JA et al. Osteoporos Int 2018. doi: 10.1007/s00198-018-4502-0

Haque S et al. Curr Treat Options in Rheum 2018; Advance online publication. doi: 10.1007/s40674-018-0099-x

Ogata T et al. Clin Rheumatol 2018; Advance online publication. doi: 10.1007/s10067-018-4106-2

Sung KH et al. Skeletal Radiol 2018; Advance online publication. doi: 10.1007/s00256-018-2876-x

Hamdy RC et al. Osteoporos Int 2018; Advance online publication. doi: 10.1007/s00198-017-4368-6

The authors suggest that opportunistic osteoporosis screening using L1 trabecular attenuation can reliably identify patients with osteoporosis based on the clinical standard of dual-energy x-ray absorptiometry.

Lee SJ, Pickhardt PJ. Clinic Rev Bone Miner Metab 2017;15:128–137. doi:10.1007/s12018-017-9235-7

In this review, the authors summarize recent literature addressing the risk factors, evaluation, and treatment for early bone fragility in patients with osteoporosis.

Grover M, Bachrach LK. Curr Osteoporos Rep 2017;15:271–282. doi:10.1007/s11914-017-0371-2

This review covers the recent advances in osteoporosis, including: Patient education, atypical femur fractures, vitamin supplementation, medication advances, post-fracture management, and screening/diagnostic modalities.

Schweser KM, Crist BD. Curr Rev Musculoskelet Med 2017;10:265–274. doi:10.1007/s12178-017-9410-y

The authors provide an overview of transient osteoporosis of the hip, covering the epidemiology, pathophysiology, etiology, diagnosis, treatment, and potential complications of the condition.1

Asadipooya K, Graves L, Greene LW. Osteoporos Int 2017;28:1805–1816. doi:10.1007/s00198-017-3952-0

This guideline, accredited by the National Institute of Health and Care Excellence, provides an overview of the assessment and management of osteoporosis for all healthcare professionals who are involved in its management.

Compston J, Cooper A, Cooper C et al. Arch Osteoporos 2017;12:43. doi:10.1007/s11657-017-0324-5

The authors review the effect of denosumab on osteoarticular erosive lesions in rheumatoid arthritis and study the potential effects of denosumab on disease activity, joint space narrowing, functional capacity, and safety.

Boleto G, Dramé M, Lambrecht I, Eschard JP, Salmon JH. Clin Rheumatol 2017;36:1699–1706. doi:10.1007/s10067-017-3722-6

Osteoporosis is increasingly recognized in children due to the increased prevalence of disorders associated with bone loss. This review explores diagnosis and treatment considerations in this population.

Marrani E et al. Drugs 2017;77:679–695. doi:10.1007/s40265-017-0715-3

Early and correct diagnosis is essential for effective therapy; this chapter explores the best approach for evaluating symptoms and making a comprehensive diagnosis of osteoporosis.

Bartl R, Bartl C. Bone Disorders. Springer International Publishing Switzerland, 2017. doi:10.1007/978-3-319-29182-6_16

An expert review of the manifestations of osteoporosis in childhood, recommendations for monitoring and prevention, and suggestions for when a child should be considered a candidate for therapy.

Ward LM, Konji VN, & Ma J. Osteoporos Int 2016;27:2147–2179. doi:10.1007/s00198-016-3515-9

Lindsay et al. conclude that osteoporosis patients at high risk for fracture being treated with teriparatide should follow the full 24-month treatment course in order to achieve the best clinical outcomes.

Lindsay R et al. Osteoporos Int 2016;27:2395–2410. doi:10.1007/s00198-016-3534-6

The authors discuss the use of dual-energy X-ray absorptiometry (DXA) and DXA-assisted technologies and their respective advantages and disadvantages in the diagnosis of osteoporosis.

Heilmeier U et al. Curr Radiol Rep 2016;4:18. doi:10.1007/s40134-016-0144-1

This review summarizes T-score derivation, how using a female database will alter male T-scores, and evaluates potential approaches to improve recognition of men at increased risk for fracture.

Binkley N, Adler R, & Bilezikian JP. Curr Osteoporos Rep 2014;12:403–409. doi:10.1007/s11914-014-0242-z

In this article, Gong et al provide an expert review of the new technologies for fracture risk prediction, diagnosis, and treatment of postmenopausal osteoporosis.

Gong B et al. Curr Osteoporos Rep 2014;12:357–365. doi:10.1007/s11914-014-0215-2